USP29 controls the stability of checkpoint adaptor Claspin by deubiquitination

Oncogene

Volumn 34, Issue 8, 2015, Pages 1058-1063

  Martin Y ^a   Cabrera, E ^a   Amoedo, H ^a   Hernandez Perez S ^a   Dominguez Kelly R ^a   Freire, R ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 1; CLSPN PROTEIN, HUMAN; DEUBIQUITINASE; PROTEIN KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UBIQUITIN THIOLESTERASE; USP29 PROTEIN, HUMAN; USP7 PROTEIN, HUMAN;

DNA REPLICATION; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN STABILITY; TUMOR CELL CULTURE; UBIQUITINATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; DNA REPLICATION; HEK293 CELLS; HUMANS; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; PROTEOLYSIS; TUMOR CELLS, CULTURED; UBIQUITIN THIOLESTERASE; UBIQUITIN-SPECIFIC PROTEASES; UBIQUITINATION;

EID: 84895915672     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.38     Document Type: Article

References (37)

1. Cimprich KA, Cortez D. ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol 2008; 9: 616-627.
2. Shiloh Y. The ATM-mediated DNA-damage response: taking shape. Trends Biochem Sci 2006; 31: 402-410.
3. Smits VAJ, Warmerdam DO, Freire R. 4. Mechanisms of ATR-mediated checkpoint signalling. Front Biosci 2010; 15: 840-853.
4. Mailand N, Falck J, Lukas C, Syljuâsen RG, Welcker M, Bartek J et al. Rapid destruction of human Cdc25A in response to DNA damage. Science 2000; 288: 1425-1429.
5. Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 1997; 277: 1501-1505.
6. Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H et al. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 1997; 277: 1497-1501.
7. Lee J, Gold DA, Shevchenko A, Shevchenko A, Dunphy WG. Roles of replication fork-interacting and Chk1-activating domains from Claspin in a DNA replication checkpoint response. Mol Biol Cell 2005; 16: 5269-5282.
8. Petermann E, Helleday T, Caldecott KW. Claspin promotes normal replication fork rates in human cells. Mol Biol Cell 2008; 19: 2373-2378.
9. Uno S, Masai H. Efficient expression and purification of human replication forkstabilizing factor, Claspin, from mammalian cells: DNA-binding activity and novel protein interactions. Genes Cells 2011; 16: 842-856.
10. Mailand N, Bekker-Jensen S, Bartek J, Lukas J. Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress. Mol Cell 2006; 23: 307-318.
11. Peschiaroli A, Dorrello NV, Guardavaccaro D, Venere M, Halazonetis T, Sherman NE et al. SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response. Mol Cell 2006; 23: 319-329.
12. Mamely I, van Vugt MA, Smits VAJ, Semple JI, Lemmens B, Perrakis A et al. Pololike kinase-1 controls proteasome-dependent degradation of Claspin during checkpoint recovery. Curr Biol 2006; 16: 1950-1955.
13. Kumagai A, Dunphy WG. Repeated phosphopeptide motifs in Claspin mediate the regulated binding of Chk1. Nat Cell Biol 2003; 5: 161-165.
14. Clarke CAL, Clarke PR. DNA-dependent phosphorylation of Chk1 and Claspin in a human cell-free system. Biochem J 2005; 388: 705-712.
15. Chini CCS, Chen J. Repeated phosphopeptide motifs in human Claspin are phosphorylated by Chk1 and mediate Claspin function. J Biol Chem 2006; 281: 33276-33282.
16. Kim JM, Kakusho N, Yamada M, Kanoh Y, Takemoto N, Masai H. Cdc7 kinase mediates Claspin phosphorylation in DNA replication checkpoint. Oncogene 2008; 27: 3475-3482.
17. Meng Z, Capalbo L, Glover DM, Dunphy WG. Role for casein kinase 1 in the phosphorylation of Claspin on critical residues necessary for the activation of Chk1. Mol Biol Cell 2011; 22: 2834-2847.
18. Verlinden L, Vanden Bempt I, Eelen G, Drijkoningen M, Verlinden I, Marchal K et al. The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor /progesterone receptor /HER-2 breast carcinomas. Cancer Research 2007; 67: 6574-6581.
19. Freire R, van Vugt MATM, Mamely I, Medema RH. Claspin: timing the cell cycle arrest when the genome is damaged. Cell Cycle 2006; 5: 2831-2834.
20. Bassermann F, Frescas D, Guardavaccaro D, Busino L, Peschiaroli A, Pagano M. The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint. Cell 2008; 134: 256-267.
21. Gao D, Inuzuka H, Korenjak M, Tseng A, Wu T, Wan L et al. Cdh1 regulates cell cycle through modulating the claspin/Chk1 and the Rb/E2F1 pathways. Mol Biol Cell 2009; 20: 3305-3316.
22. Faustrup H, Bekker-Jensen S, Bartek J, Lukas J, Mailand N. USP7 counteracts SCFbetaTrCP-but not APCCdh1-mediated proteolysis of Claspin. J Cell Biol 2009; 184: 13-19.
23. Zhang D, Zaugg K, Mak TW, Elledge SJ. A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response. Cell 2006; 126: 529-542.
24. Li M, Brooks CL, Kon N, Gu W. A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol Cell 2004; 13: 879-886.
25. Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 2002; 416: 648-653.
26. Cummins JM, Rago C, Kohli M, Kinzler KW, Lengauer C, Vogelstein B. Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature 2004; 428: 486.
27. Liu J, Chung H-J, Vogt M, Jin Y, Malide D, He L et al. JTV1 co-activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress. EMBO J 2011; 30: 846-858.
28. Jacq X, Kemp M, Martin NMB, Jackson SP. Deubiquitylating enzymes and DNA damage response pathways. Cell Biochem Biophys 2013; 67: 25-43.
29. Kumagai A, Dunphy WG. Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts. Mol Cell 2000; 6: 839-849.
30. Mosbech A, Lukas C, Bekker-Jensen S, Mailand N. The deubiquitylating enzyme USP44 counteracts the DNA double-strand break response mediated by the RNF8 and RNF168 ubiquitin ligases. J Biol Chem 2013; 288: 16579-16587.
31. Chauhan D, Tian Z, Nicholson B, Kumar KGS, Zhou B, Carrasco R et al. A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell 2012; 22: 345-358.
32. Semple JI, Smits VAJ, Fernaud J-R, Mamely I, Freire R. Cleavage and degradation of Claspin during apoptosis by caspases and the proteasome. Cell Death Differ 2007; 14: 1433-1442.
33. Domínguez-Kelly R, Martín Y, Koundrioukoff S, Tanenbaum ME, Smits VAJ, Medema RH et al. Wee1 controls genomic stability during replication by regulating the Mus81-Eme1 endonuclease. J Cell Biol 2011; 194: 567-579.
34. Pérez-Castro AJ, Freire R. Rad9B responds to nucleolar stress through ATR and JNK signalling, and delays the G1-S transition. J Cell Sci 2012; 125: 1152-1164.
35. Sowa ME, Bennett EJ, Gygi SP, Harper JW. Defining the human deubiquitinating enzyme interaction landscape. Cell 2009; 138: 389-403.
36. Refolio E, Cavero S, Marcon E, Freire R, San-Segundo PA. The Ddc2/ATRIP checkpoint protein monitors meiotic recombination intermediates. J Cell Sci 2011; 124: 2488-2500.
37. Salghetti SE, Kim SY, Tansey WP. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J 1999; 18: 717-726.